Spero Oncology Overview
- Founded
- 2014

- Status
- Acquired/Merged
- Employees
- 11

- Latest Deal Type
- M&A
- Financing Rounds
- 1
Spero Oncology General Information
Description
Operator of a clinical research organization (CRO) focused on development of oncology products. The company provides clinical operations support for oncology clinical trials primarily throughout Europe, but also in Australia and New Zealand.
Contact Information
Website
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Decision/Risk Analysis
Other Industries
Laboratory Services (Healthcare)
Pharmaceuticals
Acquirer
Primary Office
- Duart House 3 Finch Way
- Strathclyde Business Park
- Bellshill ML4 3PR
- Scotland, United Kingdom
Spero Oncology Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Spero Oncology‘s full profile, request access.
Request a free trialSpero Oncology Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Kathryn Clayton | Director, Clinical Operations | ||
Grace Flynn | Director, Contracts & Proposals | ||
Theresa Bruce | Founder & Managing Director |
Spero Oncology Signals
Growth Rate

0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile

-35.5%.
530%
Size Multiple

219x
Median
Size Multiple
219x, 100th %ile

0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial